MHC五聚体四聚体_上海宾智生物科技有限公司

MHC五聚体四聚体

属性
详情

产地：英国
关注度：次
品牌： proimmune
型号： FXXX
厂商性质：生产型,
价格： 180000
添加时间： 2014/11/9

产品介绍

Adenovirus
Publications citing Adenovirus Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*01:01	686	TDLGQNLLY	A	Adenovirus 5 Hexon 886-894
A*24:02	684	TYFSLNNKF	A	Adenovirus 5 Hexon 37-45
B*07:02	989	KPYSGTAYNAL	A	Adenovirus Hexon 114-124

Autoimmunity
Publications citing AutoImmunity Pentamers
Case studies of Customer Research into AutoImmunity

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	151	KLQVFLIVL	A	T1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13
A*02:01	954	LNIDLLWSV	A	T1D Diabetes IGRP 228–236
A*02:01	851	HLVEALYLV	A	Insulin B chain 10-18
A*02:01	393	VMNILLQYV	A	GAD65 114-122
A*02:01	470	SLSRFSWGA	A	Myelin basic protein 110-118
A*02:01	1904	VLFGLGFAI	A	T1D Diabetes IGRP 265-273

(back to top)

Cancer
Publications Citing Cancer Pentamers
Case Studies of Customer Research into Cancer

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*01:01	307	KSDICTDEY	A	Tyrosinase 243-251 (244S)
A*02:01	2291	AILALLPAL	A	Prostate Stem Cell Antigen (PSCA) 105-133
A*02:01	1920	ALLTSRLRFI	A	Telomerase Reverse Transcriptase (hTRT) 615-624
A*02:01	2083	FLAEDALNTV	A	Epithelial Discoidin Domain Receptor 1 (EDDR1) 867-876
A*02:01	2079	FLYDDNQRV	A	Topoisomerase II-alpha-b 828-836
A*02:01	1386	GLAPPQHLIRV	A	p53 187-197
A*02:01	468	ILSLELMKL	A	Receptor for hyaluronic acid–mediated motility (RHAMM) 165-173
A*02:01	1464	LTLGEFLKL	A	Survivin-3A 96-104
A*02:01	2299	SLPPPGTRV	A	p53 149-157
A*02:01	1403	VIMPCSWWV	A	Chondromodulin-I 319-327
A*02:01	1201	YMCSFLFNL	A	Ewing Tumor EZH2 666-674
A*02:01	061	YMDGTMSQV	A	Tyrosinase 369-377 (371D)
A*02:01	447	YLQVNSLQTV	A	Telomerase Reverse Transcriptase (hTRT) 988-997
A*02:01	859	KLQDASAEV	A	HM1.24-aa 126-134
A*02:01	329	ILLWQPIPV	A	Prostatic Acid Phosphatase-3 (PAP-3) 135-143
A*02:01	560	GLMEEMSAL	A	Human Mena protein (overexpressed in breast cancer)
A*02:01	813	FVGEFFTDV	A	GPC3 144-152 (overexpressed in hepatocellular carcinoma)
A*02:01	075	YLSGANLNL	S	Carcinogenic Embryonic Antigen (CEA) 571-579
A*02:01	157	VLYRYGSFSV	A	gp100 (pmel17) 476-485
A*02:01	250	VLQELNVTV	S	Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177
A*02:01	097	VISNDVCAQV	A	Prostate Specific Antigen-1 (PSA-1) 154-163
A*02:01	390	SLLMWITQV	A	NY-ESO-1 157-165
A*02:01	212	RLLQETELV	S	HER-2/neu 689-697
A*02:01	810	LIAHNQVRQV	A	HER-2/neu 85–94
A*02:01	690	LLHETDSAV	A	PSMA/PSM-P1 4-12
A*02:01	599	ALDVYNGLL	A	Prostatic acid phosphatase precursor (PAP) 299-307
A*02:01	645	YLNTVQPTCV	A	EGF-R 1138-1147
A*02:01	781	VLDGLDVLL	A	PRAME 100-108
A*02:01	689	VLAGGFFLL	A	PSMA 27-38
A*02:01	394	YLFFYRKSV	A	mTERT 572-580
A*02:01	034	FLWGPRALV	A	MAGEA3 271-279
A*02:01	646	KLFGTSGQKT	A	EGF-R-479 350-359
A*02:01	915	TLPGYPPHV	A	PAX-5 311-319
A*02:01	1056	SLFLGILSV	A	CD20 188-196 (B cell malignancies)
A*02:01	117	RLVDDFLLV	A	Telomerase Reverse Transcriptase 865-873
A*02:01	208	LLLLTVLTV	A	MUC-1 12-20
A*02:01	205	LLGRNSFEV	A	p53 264-272
A*02:01	600	ALFDIESKV	A	PSM P2 (prostate)
A*02:01	1013	FLGYLILGV	A	Prostatic Acid Phosphatase-3 (PAP-3)
A*02:01	561	TMNGSKSPV	A	hMena 502-510
A*02:01	391	LMLGEFLKL	S	Survivin 96-104
A*02:01	338	QLCPICRAPV	A	Livin/ML-IAP280 175-184
A*02:01	1181	SLSEKTVLL	A	CD59 glycoprotein precursor 106-114
A*02:01	958	SLVDVMPWL	A	Cytochrome p450 1B1 239-248
A*02:01	214	KIFGSLAFL	A	HER-2/neu 369-377
A*02:01	046	IMDQVPFSV	S	gp100 (pmel17) 209-217
A*02:01	210	ILHNGAYSL	A	HER-2/neu 435-443
A*02:01	085	ILAKFLHWL	S	Telomerase 540-548
A*02:01	249	HLSTAFARV	A	G250 (renal cell carcinoma) 217-225
A*02:01	125	GVLVGVALI	A	Carcinogenic Embryonic Antigen (CEA) 694-702
A*02:01	527	ALYVDSLFFL	A	PRAME PRA 300–309
A*02:01	405	KLQCVDLHV	A	Prostate Specific Antigen 146-154
A*02:01	086	ALQPGTALL	A	Prostate Stem Cell Antigen (PSCA) 14-22
A*02:01	302	KVAELVHFL	A	MAGEA3 112-120
A*02:01	057	KTWGQYWQV	A	gp100 (pmel17) 154-162
A*02:01	389	GLYDGMEHL	A	MAGEA-10 254-262
A*02:01	404	FLTPKKLQCV	A	Prostate Specific Antigen-1 (PSA-1) 141-150
A*02:01	082	ELAGIGILTV	s	MelanA / MART 26-35
A*02:01	171	KVLEYVIKV	A	MAGEA1 278-286
A*02:01	2293	GLQHWVPEL	A	BA46 (Lactadherin) 97-106
A*02:01	2294	GVRGRVEEI	A	bcr-abl fusion protein
A*02:01	048	YLSGADLNL	A	Carcinoembryonic antigen (CEA)-derived peptide CAP1-6D
A*02:01	2296	ITDQVPFSV	A	gp100 (pmel) 209-217
A*02:01	047	YLEPGPVTV	A	gp100 (pmel) 280-288 (288V)
A*02:01	2301	YLQLVFGIEV	A	MAGEA2 157-166
A*02:01	2298	KVAEELVHFL	A	MAGEA3 112-120 (alternative version)
A*02:01	049	SLLMWITQC	A	NY-ESO-1 157-165 (9C)
A*02:01	2300	YLGSYGFRL	A	p53 103-111
A*02:01	2297	KLCPVQLWV	A	p53 139-147
A*02:01	654	RMPEAAPPV	A	p53 65-73
A*02:01	1787	RLTSRVKAL	A	Telomerare Reverse Transcriptase (hTRT) 653-661
A*02:01	1786	GLLGASVLGL	A	Telomerase Reverse Transcriptase (hTRT) 674-683
A*02:01	381	LLLTVLTVV	A	Tumor Mucin Antigen 13-21
A*03:01	118	ALLAVGATK	A	gp100 (pmel17) 17-25
A*03:01	264	ATGFKQSSK	A	bcr-abl 210 kD fusion protein 259-269
A*03:01	087	KQSSKALQR	S	bcr-abl 210 kD fusion protein 21-29
A*03:01	541	RISTFKNWPK	A	Survivin-3A 18-27 (27K)
A*24:02	416	EYLQLVFGI	A	MAGEA2 156-164
A*24:02	421	TFPDLESEF	A	MAGEA3 97-105
A*24:02	209	TYACFVSNL	A	Carcinogenic Embryonic Antigen (CEA) 652-660
A*24:02	417	TYLPTNASL	A	HER-2/neu 63-71
A*24:02	418	VYGFVRACL	A	Telomerase reverse transcriptase (hTRT) 461-469
A*24:02	230	AFLPWHRLF	A	Tyrosinase 188-196
A*24:02	2303	CYASGWGSI	A	Prostate Specific Antigen-1 153-161
A*24:02	238	VYFFLPDHL	A	gp100-intron 4 170-178
A*24:02	1806	RYCNLEGPPI	A	Lymphocyte antigen 6 complex locus K (LY6K) 177-186
A*24:02	2302	AYACNTSTL	A	Survivin 80-88
B*07:02	2304	LPWHRLFLL	A	Tyrosinase 208-216
B*08:01	094	GFKQSSKAL	A	bcr-abl 210 kD fusion protein 19-27
B*35:01	2307	MPFATPMEA	A	NY-ESO-1 94-102
H-2 Db	1731	ATFKNWPFL	A	Murine Survivin 20-28
H-2Db	695	Abu-Abu-L-Abu-LTVFL	A	Moloney murine sarcoma virus (MoMSV) GagL 85–93
H-2Db	2199	FSNSTNDILI	A	VEGFR2/KDR fragment 1 614-624
H-2Db	1333	KVPRNQDWL	A	gp100 (pmel17) 25-33
H-2Kb	185	SVYDFFVWL	A	Tyrosinase related protein-2 180-188
H-2Kb	351	HNTQYCNL	A	MAGEA5 5-12
H-2Kb	2311	TVSEFLKL	A	Murine Survivin 97-104
H-2Kd	0275	DYWGQGTEL	A	Surface IgG (sA20-Ig) of A20 106-114
H-2Kd	814	EYILSLEEL	A	GPC3 298-306
H-2Kd	343	TYVPANASL	A	neu/HER-2/Erbb2 proto-oncoprotein 66-74
H-2Ld	150	LPYLGWLVF	A	Tumour Antigen P815 35-43

(back to top)

Chlamydia

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	334	RLNMFTPYI	A	Chlamydia trachomatis MOMP 258-266

(back to top)

CMV
Publications citing CMV Pentamers
Case Studies of Customer Research into CMV

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*01:01	739	VTEHDTLLY	A	HCMV pp50 245-253
A*01:01	266	YSEHPTFTSQY	A	HCMV pp65 363-373
A*02:01	1598	VLAELVKQI	A	HCMV IE1 81-89
A*02:01	008	NLVPMVATV	S	HCMV pp65 495-504
A*03:01	1599	KLGGALQAK	A	HCMV IE1 184-192
A*24:02	414	QYDPVAALF	A	HCMV pp65 341-349
A*24:02	380	VYALPLKML	A	HCMV pp65 113-121
B*07:02	045	TPRVTGGGAM	S	HCMV pp65 417-426
B*07:02	308	RPHERNGFTVL	A	HCMV pp65 265-275
B*08:01	691	QIKVRVDMV	A	HCMV IE1 88-96
B*35:01	114	IPSINVHHY	A	HCMV pp65 123-131
H-2Db	2313	HGIRNASFI	A	MCMV m45 985-993
H-2Dd	278	AGPPRYSRI	A	MCMV m164 257-265
H-2Ld	021	YPHFMPTNL	S	MCMV IE1 168-176

(back to top)

EBV
Publications citing EBV Pentamers
Case Studies of Customer Research into EBV

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	666	FLYALALLL	A	EBV LMP-2 356-364
A*02:01	001	GLCTLVAML	S	EBV BMLF-1 259-267
A*02:01	042	CLGGLLTMV	S	EBV LMP-2 426-434
A*02:01	409	YLLEMLWRL	A	EBV LMP-1 125-133
A*02:01	2292	FLDKGTYTL	A	EBV BALF-4 276–284
A*03:01	727	RLRAEAQVK	A	ENV EBNA 3A 603–611
A*11:01	639	ATIGTAMYK	A	EBV BRLF1 134-142
A*11:01	199	IVTDFSVIK	A	EBV EBNA-4 416-424
A*11:01	508	SSCSSCPLSK	A	EBV LMP-2 340-349
A*24:02	648	PYLFWLAAI	A	EBV LMP2 131-139
A*24:02	683	TYGPVFMSL	A	EBV LMP2 419–427
A*24:02	420	TYGPVFMCL	A	EBV LMP-2 419-427
B*07:02	044	RPPIFIRRL	S	EBV EBNA-3A 247-255
B*07:02	2305	QPRAPIRPI	A	EBV EBNA-3C 881-889
B*08:01	190	RAKFKQLL	S	EBV BZLF-1 190-197
B*08:01	073	FLRGRAYGL	S	EBV EBNA-3A 193-201
B*08:01	489	QAKWRLQTL	A	EBV EBNA3A 158-166
B*35:01	387	HPVGEADYFEY	A	EBV EBNA-1 407-417
B*35:01	399	EPLPQGQLTAY	A	EBV BZLF-1 54-64
B*40:01	692	IEDPPFNSL	A	EBV LMP2 200-208

(back to top)

HBV
Publications citing HBV Pentamers
Case Studies of Customer Research into Hepatitis

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	032	FLLSLGIHL	S	HBV polymerase 573-581
A*02:01	027	FLLTRILTI	S	HBV envelope 183-191
A*02:01	023	FLPSDFFPSV	S	HBV core antigen 18-27
A*02:01	028	GLSPTVWLSV	A	HBV surface antigen 185-194
A*02:01	031	WLSLLVPFV	S	HBV surface antigen 172-181
A*02:01	283	FLPSDFFPSI	A	HBV core 18-27 (subtype ADR4)
A*11:01	377	YVNVNMGLK	A	HBV core antigen 88-96
A*24:02	413	KYTSFPWLL	A	HBV polymerase 756-764
A*24:02	378	EYLVSFGVW	A	HBV core 117-125
H-2Kb	422	ILSPFLPLL	A	HBV surface antigen 208-216
H-2Kb	1431	MGLKFRQL	A	HBV core 93-100
H-2Kb	477	VWLSVIWM	A	HBV Surface antigen 190-197
H-2Ld	129	IPQSLDSWWTSL	S	HBV surface antigen 28-39

(back to top)

HCV
Publications citing HCV Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*01:01	1066	ATDALMTGF	A	HCV NS3 1436-1444
A*01:01	740	ATDALMTGY	A	HCV NS3 1435-1443
A*02:01	036	VLSDFKTWL	A	HCV NS5a 1987-1995
A*02:01	172	LLFNILGGWV	A	HCV NS4b 1807-1816
A*02:01	242	KLSGLGINAV	A	HCV NS3 1406-1415
A*02:01	1094	GLQDCTMLV	A	HCV NS5B 2727-2735
A*02:01	003	CINGVCWTV	A	HCV NS3 1073-1081
A*02:01	004	YLLPRRGPRL	A	HCV core 35-44
A*02:01	002	DLMGYIPAV	S	HCV core 132-140
A*02:01	491	DLMGYIPLV	A	HCV core 132-140
A*02:01	040	KLVALGINAV	A	HCV NS3 1406-1415
A*02:01	858	CVNGVCWTV	A	HCV NS3 1073-1081
A*02:01	037	ALYDVVTKL	A	HCV NS5b 2594-2602
A*03:01	035	RVCEKMALY	A	HCV NS5B 2588-2596
A*24:02	415	AYSQQTRGL	A	HCV NS3 1031-1039
B*07:02	845	DPRRRSRNL	A	HCV core 111-119
B*07:02	742	GPRLGVRAT	A	HCV core 41-49
B*08:01	721	HSKKKCDEL	A	HCV NS3 1395-1403
B*35:01	565	HPNIEEVAL	A	HCV NS3 1359-1367
B*35:01	942	CPNSSIVY	A	HCV E1 207-214
B*40:01	939	REISVPAEIL	A	HCV NS5a 2266-2275
H-2Db	791	GAVQNEVTL	A	HCV NS3 1629-1637

(back to top)

HIV
Publications citing HIV Pentamers
Case Studies of Customer Research into HIV

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	430	GLADQLIHL	A	HIV-1 Vif 101-109
A*02:01	799	LTFGWCFKL	A	HIV-1 Nef 137-145
A*02:01	084	ILKEPVHGV	S	HIV-1 RT 476-484
A*02:01	246	KLTPLCVTL	A	HIV-1 env gp120 90-98
A*02:01	010	SLYNTVATL	S	HIV-1 gag p17 76-84
A*02:01	174	TLNAWVKVV	A	HIV-1 gag p24 19-27
A*03:01	194	RLRPGGKKK	S	HIV-1 gag p17 19-27
A*03:01	109	QVPLRPMTYK	S	HIV-1 nef 73-82
A*24:02	419	RYLKDQQLL	A	HIV-1 gag gp41 67-75
A*24:02	411	RYPLTFGWCY	A	HIV-1 Nef 134-143
B*07:02	257	TPGPGVRYPL	S	HIV-1 nef 128-137
B*07:02	196	IPRRIRQGL	A	HIV-1 env gp120 848-856
B*07:02	877	GPGHKARVL	A	HIV gag p24 223–231
B*08:01	193	FLKEKGGL	S	HIV-1 nef 90-97
B*08:01	195	GEIYKRWII	A	HIV-1 gag p24 261-269
B*15:01	1072	RLRPGGKKKY	A	HIV-1 p17 20-29
B*27:05	294	KRWIILGLNK	A	HIV-1 gag p24 265-274
B*27:05	874	KRWIIMGLNK	A	HIV-1 gag p24 263-272
B*27:05	2306	GRAFVTIGK	A	HIV-1 gp100 103-111
B*35:01	255	NPDIVIYQY	A	HIV-1 RT 328-336
B*35:01	1211	VPLDEDFRKY	A	HIV-1 RT 273-282
B*40:01	840	KEKGGLEGL	A	HIV-1 Nef 92-100
H-2Dd	177	RGPGRAFVTI	A	HIV-1 IIIB gp120 318-327
H-2Dd	1684	IGPGRAFYA	A	HIV-1 US4 gp120 318-326
H-2Kd	176	AMQMLKETI	A	HIV-1 gag p24 199-207

(back to top)

HPV

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	095	YMLDLQPETT	S	HPV 16 E7 11-20
A*02:01	2312	MLDLQPETT	A	HPV 16 E7 12-20
A*03:01	2064	KLCLRFLSK	A	HPV 33 E6 64-72
B*07:02	2065	KPTLKEYVL	A	HPV 33 E7 5-13
H-2Db	502H	RAHYNIVTF	A	HPV 16 E7 49-57

(back to top)

HTLV
Publications citing HTLV Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	200	LLFGYPVYV	A	Human T-cell lymphotropic virus-1 Tax 11-19
A*02:01	2309	AVLDGLLSL	A	HTLV bZIP factor 42-50
A*24:02	1043	SFHSLHLLF	A	Human T-cell lymphotropic virus-1 Tax 301-309

(back to top)

Influenza
Publications citing Influenza Pentamers
Case Studies of Customer Research into Influenza

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*01:01	076	CTELKLSDY	A	Influenza A (PR8) NP 44-52
A*01:01	540	VSDGGPNLY	A	Influenza A PB1 591-599
A*02:01	007	GILGFVFTL	S	Influenza A MP 58-66
A*02:01	2295	ILGFVFTLTV	A	Influenza A MP 59-68
A*03:01	77	ILRGSVAHK	A	Influenza A (PR8) NP 265-274
A*11:01	1513	SIIPSGPLK	A	Influenza A MP 13-21
A*11:01	1720	RMVLASTTAK	A	Influenza A MP1 178-187
A*11:01	1722	KSMREEYRK	A	Influenza A MP2 70-78
B*07:02	1744	SPIVPSFDM	A	Influenza A NP 473-481
B*07:02	1743	QPEWFRNVL	A	Influenza A PB1 329-337
B*27:05	463	SRYWAIRTR	A	Influenza A NP 383-391
H-2Db	119	ASNENMETM	S	Influenza A (PR8) NP 366-374
H-2Db	009	ASNENMDAM	S	Influenza A (NT60) NP 366-374
H-2Db	120	SSLENFRAYV	A	Influenza A (PR8) Polymerase acidic protein 224-233
H-2Kd	098	TYQRTRALV	S	Influenza A (PR8) NP 147-155
H-2Kd	240	IYSTVASSL	A	Influenza A HA 533-541

(back to top)

LCMV
Publications citing LCMV Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	2308	ALPHIIDEV	A	LCMV envelope gp 10-18
A*02:01	2310	YLVSIFLHL	A	LCMV envelope gp 447-455
H-2Db	070	FQPQNGQFI	S	LCMV NP 396-404
H-2Db	069	KAVYNFATC	S	LCMV GP1 33-41
H-2Db	186	SGVENPGGYCL	A	LCMV GP 276-286
H-2 Kb	2076	ISHNFCNL	A	LCMV GP 118-125

(back to top)

Listeria
Publications citing Listeria Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
H-2Kd	178	GYKDGNEYI	A	Listeria monocytogenes Listeriolysin 91-99

(back to top)

Malaria
Publications citing Malaria Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	314	YLNKIQNSL	A	Plasmodium falciparum CSP 334-342
H-2Kd	771	YYIPHQSSL	A	Plasmodium falciparum Liver stage antigen 1671-1679
H-2Kd	376	SYIPSAEKI	A	Plasmodium berghei CSP 252-260

(back to top)

miHAg
Publications citing miHAg Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	581	RTLDKVLEV	A	miHAg HA-8
A*02:01	175	FIDSYICQV	A	miHAg H-Y (human SMCY) 311-319
A*02:01	473	VLHDDLLEA	A	miHAg HA-1 137-145
B*07:02	1113	SPSVDKARAEL	A	miHAg SMCY 1041-1051
H-2Db	328	KCSRNRQYL	A	miHAg SMCY 738-746
H-2Db	327	WMHHNMDLI	S	miHAg UTY 246-254

(back to top)

Model Antigen
Publications citing Model Antigen Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
H-2Kb	093	SIINFEKL	S	Ovalbumin 257-264
H-2Kb	908	KVVRFDKL	A	Ovalbumin (subdominant) 55-62
H-2Kb	562	LTFNYRNL	A	Histocompatibility antigen 60 39-46
H-2Kb	1803	SIYRYYGL	A	Synthetic variant of VSV Nucleoprotein 498–505
H-2Kd	198	HYLSTQSAL	A	Enhanced Green Fluorescent Protein (eGFP) 200-208
H-2Ld	074	TPHPARIGL	S	E. coli beta-galactosidase 876-884

(back to top)

Negative

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	N01	NEGATIVE	S	Negative Control

(back to top)

Other
Publications citing other Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	366	LMWYELSKI	A	KSHVF-8 gB.492-500
A*02:01	773	VLPLTVAEV	A	Mesothelin 530–538
A*02:01	1152	VLMIKALEL	A	Non muscle Myosin-9 741-749
A*02:01	353	RILGAVAKV	A	Vinculin 822-830
A*02:01	133	LLDVPTAAV	A	Interferon gamma inducible protein (GILT) 30 27-35
A*02:01	1153	QLFNHTMFI	A	Non-muscle Myosin 478-486
E*01:01	712	VMAPRTLIL	A	HLA-C leader sequence peptide
H-2Kb	188	SSIEFARL	A	HSV-1 gp B 498-505
H-2Kb	828	KSPWFTTL	A	MuLV env 622-629
H-2Kb	488	VVYDFLKL	A	SV40 T antigen 404-411
H-2Kd	062	RYLKNGKETL	A	HLA-Cw3 170-179
H-2Kd	458	KYNKANVFL	A	NRP-V7 superagonist peptide 8.3 Tg NOD mouse
H-2Ld	398	SPSYVYHQF	A	MuLV env gp70 423-431

(back to top)

RSV
Publications citing RSV Pentamers
Case Studies of Customer Research into Viral Diseases

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	801	KMLKEMGEV	A	RSV NP 137-145
H-2Kd	154	SYIGSINNI	A	RSV M2 82-90
H-2Kd	149	KYKNAVTEL	A	RSV A strain F protein 85-93

(back to top)

Sendai Virus

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
H-2Kb	056	FAPGNYPAL	S	Sendai virus NP 324-332

(back to top)

SIV

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
Mamu-A*01	1110	CTPYDINQM	A	SIV Gag 181-189
Mamu-A*02	1111	YTSGPGIRY	A	SIV Nef 159-167
Mamu-A*02	1112	GSENLKSLY	A	SIV Gag 71-79

(back to top)

Trypanosoma
Publications citing Trypanosoma Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
H-2Kb	964	VNHRFTLV	A	Trypanosoma cruzi ASP-2 553-560
H-2Kb	708	ANYNFTLV	A	Trypanosoma cruzi SP 536-543

(back to top)

Tuberculosis
Publications citing Tuberculosis Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	324	GLPVEYLQV	A	Mycobacterium bovis antigen 85-A 6-14
A*02:01	276	KLIANNTRV	A	Mycobacterium bovis antigen 85-A 200-208
H-2Db	547	AIQGNVTSI	A	Mycobacterium tuberculosis ESAT-6 17-25
H-2Kb	769	IMYNYPAML	A	Mycobacterium tuberculosisTB10.4 4-12
H-2Kb	764	IMYNYPAM	A	Mycobacterium tuberculosisTB10.4 4-11
H-2Ld	158	MPVGGQSSF	A	Mycobacterium tuberculosis Ag85A 70–78

(back to top)

Vaccinia Virus
Publications citing Vaccinia Pentamers

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	978	ILDDNLYKV	A	Vaccinia virus Copenhagen Protein G5 18-26
A*02:01	703	KVDDTFYYV	A	Vaccinia virus Host range protein 2 74-82
H-2Kb	733	TSYKFESV	A	Vaccinia virus WR epitope B8R 20-27

(back to top)

Vesicular Stomatitis Virus

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
H-2Kb	373	RGYVYQGL	A	VSV NP 52
H-2Ld	622	MPYLIDFGL	A	VSV N 275-283

(back to top)

West Nile Virus

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
A*02:01	1320	RLDDDGNFQL	A	West Nile Virus NY-99 polyprotein precursor (1452-1461)
A*02:01	1327	YTMDGEYRL	A	West Nile virus NY-99 polyprotein precursor 2023-2031
A*02:01	1322	ATWAENIQV	A	West Nile virus NY-99 polyprotein precursor 3390-3398
H-2Db	663	LGMSNRDFL	A	West Nile Virus polyprotein 294-302

(back to top)

Yellow Fever

ALLELE	PEPTIDE CODE	PEPTIDE SEQUENCE	Stock/ Available	EPITOPE ORIGIN
H-2Kb	1182	ATLTYRML	A	Yellow Fever Virus 17D polyprotein 268-275

公司简介
来宝会员

上海宾智生物科技有限公司是一家致力于生命科学和生物技术领域的高科技企业。公司由在国内科研试剂领域有着十几年从业经验的专业技术团队和企业管理团队组建而成，专门从事以…... 了解更多>>

返回首页
一键联系
留言

*
*
*
*